Sorry Chil020, can't say I agree even slightly.
The science behind EBC-46 is far less accessible - in fact I can't find any.
The credentials of the Board and management don't impress other than that they seem strong on Eco-qualifications and marketing.
To compare the mode of action describes for EBC46 with cVac is, frankly, silly - they are so far apart no comparison can be made.
Before i invested 0.01c in such a venture I'd want to see far more than an attempt to jump on the cancer immunotherapy train before it leaves the station (the DNDN engine is being stoked as we speak), and atm I can't see anything else for this company.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $350.4M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 24.0¢ | $225.8K | 931.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 288990 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 21838 | 3 |
View Market Depth
| Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |